Editorial: which iron preparation for patients with IBD? Authors' reply
Aliment Pharmacol Ther
.
2017 Jul;46(2):195-196.
doi: 10.1111/apt.14126.
Authors
A Aksan
1
2
,
H Işık
3
,
H H Radeke
2
4
,
A Dignass
2
5
,
J Stein
2
6
Affiliations
1
Faculty of Health Sciences, Hacettepe University, Ankara, Turkey.
2
Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany.
3
Faculty of Sciences, Hacettepe University, Ankara, Turkey.
4
Pharmazentrum Frankfurt, Institute of Pharmacology and Toxicology, Hospital of the Goethe University, Frankfurt/Main, Germany.
5
Department of Gastroenterology, Agaplesion Markus Krankenhaus, Frankfurt/Main, Germany.
6
Department of Gastroenterology and Clinical Nutrition, DGD Clinics Sachsenhausen, Frankfurt/Main, Germany.
PMID:
28621074
DOI:
10.1111/apt.14126
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Inflammatory Bowel Diseases*
Iron*
Substances
Iron